Kestra Medical Technologies (KMTS) Equity Ratio (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Equity Ratio data on file, last reported at 0.76 in Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.76, up 131.79% year-over-year; the trailing twelve-month figure through Jan 2026 was 0.76 (up 131.79% YoY), and the FY2025 annual result was 0.69, up 115.24% from the prior year.
• Equity Ratio climbed to 0.76 in Q1 2026 per KMTS's latest filing, from 0.67 in the prior quarter.
• Over five years, Equity Ratio peaked at 0.76 in Q1 2026 and troughed at 4.56 in Q2 2024.
• A 3-year average of 0.69 and a median of 0.68 in 2025 frame the typical range for Equity Ratio.
• The sharpest annual moves came in 2025 and 2026: Equity Ratio soared 115.24% in 2025, then jumped 131.79% in 2026.
• A 3-year view of Equity Ratio shows it stood at 4.56 in 2024, then jumped by 114.6% to 0.67 in 2025, then grew by 14.15% to 0.76 in 2026.
• Business Quant data shows KMTS's Equity Ratio at 0.76 in Q1 2026, 0.67 in Q4 2025, and 0.69 in Q3 2025.